TI-7006

N/A

Report date: 2026/03/19 17:01:35

Base Information

Drug NameTI-7006
Drug Alias NameTI-7006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Tetraspecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionProgrammed death-ligand 1 blockersAnti-IL15Anti-CD3 +[4] 
TargetsProgrammed death-ligand 1Interleukin-15T cell surface glycoprotein CD3 +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Timmune Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Timmune Biotech Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A